PPE: The impact of cotrimoxazole on healthy birth and growth in rural Zimbabwe. (360G-Wellcome-108065_Z_15_A)

£40,000

The goal of this proposal is to evaluate the impact of cotrimoxazole, integrated with a package of nutrition interventions early in the lifecourse, on healthy birth and growth in rural Zimbabwe. Stunting is highly prevalent, begins in utero and causes increased mortality and reduced long-term productivity. Current nutrition-specific interventions have only a marginal impact. New approaches targeting mechanistic pathways early in the life-cycle are needed. We will use cotrimoxazole to test the hy pothesis that inflammation is a common mechanism underlying preterm birth, intrauterine growth restriction and postnatal stunting. We hypothesize that inflammation is driven predominantly by clinical and subclinical infections, abnormal micobiota composition and environmental enteric dysfunction, all of which will be impacted by cotrimoxazole. The specific questions are: 1) Does antenatal cotrimoxazole improve fetal growth and reduce prematurity? 2) Does postnatal cotrimoxazole improve li near growth? 3) Through what mechanistic pathways does cotrimoxazole operate? We will conduct a randomised clinical trial of cotrimoxazole, integrated with a package of evidence-based nutrition interventions, in two phases. First, women will receive a lipid-based nutrient supplement (LiNS) and nutrition education during pregnancy and will be randomised to daily cotrimoxazole or placebo, with a primary outcome of birth weight. Second, breastfeeding women will continue to receive LiNS and nut rition education; their infants will be randomised to daily cotrimoxazole or placebo, with a primary outcome of height-for-age Z-score at 6 months. Finally, we will investigate the impact of cotrimoxazole on underlying biological pathways to better understand its mechanism of action.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 40000
Applicant Surname Prendergast
Approval Committee Science Interview Panel
Award Date 2015-07-07T00:00:00+00:00
Financial Year 2014/15
Grant Programme: Title Provision for Public Engagement
Internal ID 108065/Z/15/A
Lead Applicant Prof Andrew Prendergast
Partnership Value 40000
Planned Dates: End Date 2023-07-01T00:00:00+00:00
Planned Dates: Start Date 2016-01-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London
Sponsor(s) Dr Jean Humphrey, Prof Thomas MacDonald